Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population [Phase 4]
Phase 4 clinical trial in Bangladesh comparing atorvastatin/ezetimibe fixed-dose combination (10/10 mg) to atorvastatin 20 mg monotherapy fo…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients [NA]
A clinical trial led by the West Virginia School of Osteopathic Medicine is evaluating lifestyle medicine approaches to chronic disease mana…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention [NA]
Clinical trial update on the completion and results posting of a study evaluating pharmacist interventions in lipid management for secondary…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: The Medication Experience Study [NA]
The Medication Experience Study sponsored by Wake Forest University has completed, examining patients with hypertension, hyperlipidemia, dia…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Effect of Plasma Ceramides on Peripheral Vascular Function [NA]
Completed clinical trial assessing whether plasma ceramides affect peripheral vascular function.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-26FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for pravastatin sodium from Dr. Reddy's Laboratories Limited. This pertains to a generic pravastatin…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland [NA]
A clinical trial update from the University of Geneva evaluating the myCare Start Service in Switzerland to support patients starting new me…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Developing an AI Pharmacy Chatbot for the Population of Hong Kong [NA]
This clinical trial update describes the development of an AI pharmacy chatbot for the Hong Kong population. The study targets individuals w…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating safety and pharmacokinetics of SHR-1209 administered by single-site or multi-site subcutaneous injections in health…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. [Phase 2]
Phase 2 clinical trial evaluating the effect of a sinbiotic with multispecies probiotics on liver parameters in patients with MASLD/MASH; tr…
-
FDA approval · 2025-06-13FDA Approved: PITAVASTATIN — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for pitavastatin calcium by Teva Pharmaceuticals, updating/expanding the existing approval for this …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI [NA]
A clinical trial is evaluating adding a PCSK9 inhibitor to high-intensity statin therapy to prevent cardiovascular events in patients with a…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. [Phase 3]
A Phase 3 trial evaluating Obicetrapib in patients with familial hypercholesterolemia on maximally tolerated lipid-modifying therapy has com…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity [EARLY_Phase 1]
An early-phase (Phase 1) pilot trial of GLY-LOW supplementation in postmenopausal women with obesity has completed, according to the clinica…
-
FDA approval · 2025-06-06FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved the supplemental application for Lipofen (fenofibrate) submitted by ANI Pharmaceuticals, Inc., granting regulatory approval…
-
FDA approval · 2025-06-06FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approves a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2025-05-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)
FDA approved a supplemental abbreviated new drug application (ANDA) for Apotex Corp. to market a generic fixed-dose combination of amlodipin…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C [Phase 3]
Phase 3 study of K-877 (pemafibrate) in Chinese patients with high triglycerides and low HDL-C has completed.
-
FDA approval · 2025-05-22FDA Approved: FENOFIBRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for fenofibrate (generic) under ANDA 201748, authorizing the mar…
-
FDA approval · 2025-05-22FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' fixed-dose combination of amlodipine and atorvastatin under an original ANDA application.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI
This clinical trial update describes the LDL-cholesterol levels attained in patients who achieved ≥50% LDL reduction after percutaneous coro…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Impact of Phytosterol-Rich Extract on Lipid Profile [NA]
This clinical trial update describes an investigation of a phytosterol-rich extract and its effect on lipid profiles in individuals with ele…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: HeartBeet Clinic Pilot Trial [NA]
The HeartBeet Clinic Pilot Trial, sponsored by HealthPartners Institute, has completed. It concerns hyperlipidemia and hypertension.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia [NA]
A completed clinical trial evaluating the effects of Barberry on cardiometabolic risk factors in individuals with hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022 [Phase 1]
A Phase 1 ascending-dose study evaluating the safety, tolerability, and pharmacokinetics of RBD7022 in relation to hyperlipidemia has comple…